Liothyronine I-131 has been used in trials studying the treatment of Tricuspid Atresia and Heart Defects, Congenital.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Conjugated estrogens | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Conjugated estrogens. |
| Floxuridine | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Floxuridine. |
| Methadone | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Methadone. |
| Fluorouracil | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Fluorouracil. |
| Clofibrate | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Clofibrate. |
| Mitotane | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Mitotane. |
| Tamoxifen | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Tamoxifen. |
| Diamorphine | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Diamorphine. |
| 5-fluorouridine | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with 5-fluorouridine. |
| Tegafur | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Tegafur. |
| Synthetic Conjugated Estrogens, A | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Synthetic Conjugated Estrogens, A. |
| Synthetic Conjugated Estrogens, B | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Synthetic Conjugated Estrogens, B. |
| Esterified estrogens | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Esterified estrogens. |
| Diethylstilbestrol | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Diethylstilbestrol. |
| Estradiol | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Estradiol. |
| Ethinylestradiol | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Ethinylestradiol. |
| Mestranol | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Mestranol. |
| Estrone sulfate | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Estrone sulfate. |
| Quinestrol | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Quinestrol. |
| Hexestrol | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Hexestrol. |
| Estradiol acetate | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Estradiol acetate. |
| Estradiol cypionate | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Estradiol cypionate. |
| Estradiol valerate | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Estradiol valerate. |
| Estriol | The therapeutic efficacy of Liothyronine I-131 can be decreased when used in combination with Estriol. |
| Asparaginase Escherichia coli | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Asparaginase Escherichia coli. |
| Pegaspargase | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Pegaspargase. |
| Niacin | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Niacin. |
| Asparaginase Erwinia chrysanthemi | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Asparaginase Erwinia chrysanthemi. |
| Fluticasone propionate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Fluticasone propionate. |
| Oxandrolone | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Oxandrolone. |
| Testosterone | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Testosterone. |
| Prednisone | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Prednisone. |
| Nandrolone phenpropionate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Nandrolone phenpropionate. |
| Danazol | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Danazol. |
| Testosterone propionate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Testosterone propionate. |
| Stanolone | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Stanolone. |
| Oxymetholone | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Oxymetholone. |
| Methyltestosterone | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Methyltestosterone. |
| Stanozolol | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Stanozolol. |
| Testosterone succinate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Testosterone succinate. |
| Nandrolone decanoate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Nandrolone decanoate. |
| Meprednisone | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Meprednisone. |
| Nandrolone | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Nandrolone. |
| Testosterone cypionate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Testosterone cypionate. |
| Testosterone enanthate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Testosterone enanthate. |
| Testosterone undecanoate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Testosterone undecanoate. |
| Prednisone acetate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Prednisone acetate. |
| Fluocinonide | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Fluocinonide. |
| Ciclesonide | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Ciclesonide. |
| Fluticasone furoate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Fluticasone furoate. |
| Beclomethasone dipropionate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Beclomethasone dipropionate. |
| Phenytoin | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Phenytoin. |
| Liothyronine | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Liothyronine. |
| Levothyroxine | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Levothyroxine. |
| Mephenytoin | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Mephenytoin. |
| Carbamazepine | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Carbamazepine. |
| Furosemide | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Furosemide. |
| Nitrofurantoin | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Nitrofurantoin. |
| Ethotoin | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Ethotoin. |
| Meclofenamic acid | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Meclofenamic acid. |
| Heparin | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Heparin. |
| Dantrolene | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Dantrolene. |
| Fosphenytoin | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Fosphenytoin. |
| Liotrix | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Liotrix. |
| Etofenamate | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Etofenamate. |
| Neocitrullamon | The therapeutic efficacy of Neocitrullamon can be increased when used in combination with Liothyronine I-131. |
| Allantoin | The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Allantoin. |